Zobrazeno 1 - 10
of 11 177
pro vyhledávání: '"Gershenwald, JE"'
Autor:
Buller DB; David B. Buller, Julia Berteletti, and Irene Adjei are with Klein Buendel Inc, Golden, CO. Carolyn Heckman and Anna Mitarotondo are with the Rutgers Cancer Institute, Rutgers University, New Brunswick, NJ. Kevin R. J. Schroth is with the School of Public Health, Rutgers University, New Brunswick. Alan C. Geller is with the T. H. Chan School of Public Health, Harvard University, Cambridge, MA. Jerod L. Stapleton is with the College of Public Health, University of Kentucky, Lexington. Samantha R. Guild is with the AIM at Melanoma Foundation, Frisco, TX. Jeffrey E. Gershenwald is with the M D Andersen Cancer Center, University of Texas, Houston. Robert Dellavalle is with the Medical School, University of Minnesota, Minneapolis. Sherry Pagoto is with the Department of Allied Health Sciences, University of Connecticut, Storrs., Berteletti J; David B. Buller, Julia Berteletti, and Irene Adjei are with Klein Buendel Inc, Golden, CO. Carolyn Heckman and Anna Mitarotondo are with the Rutgers Cancer Institute, Rutgers University, New Brunswick, NJ. Kevin R. J. Schroth is with the School of Public Health, Rutgers University, New Brunswick. Alan C. Geller is with the T. H. Chan School of Public Health, Harvard University, Cambridge, MA. Jerod L. Stapleton is with the College of Public Health, University of Kentucky, Lexington. Samantha R. Guild is with the AIM at Melanoma Foundation, Frisco, TX. Jeffrey E. Gershenwald is with the M D Andersen Cancer Center, University of Texas, Houston. Robert Dellavalle is with the Medical School, University of Minnesota, Minneapolis. Sherry Pagoto is with the Department of Allied Health Sciences, University of Connecticut, Storrs., Heckman C; David B. Buller, Julia Berteletti, and Irene Adjei are with Klein Buendel Inc, Golden, CO. Carolyn Heckman and Anna Mitarotondo are with the Rutgers Cancer Institute, Rutgers University, New Brunswick, NJ. Kevin R. J. Schroth is with the School of Public Health, Rutgers University, New Brunswick. Alan C. Geller is with the T. H. Chan School of Public Health, Harvard University, Cambridge, MA. Jerod L. Stapleton is with the College of Public Health, University of Kentucky, Lexington. Samantha R. Guild is with the AIM at Melanoma Foundation, Frisco, TX. Jeffrey E. Gershenwald is with the M D Andersen Cancer Center, University of Texas, Houston. Robert Dellavalle is with the Medical School, University of Minnesota, Minneapolis. Sherry Pagoto is with the Department of Allied Health Sciences, University of Connecticut, Storrs., Schroth KRJ; David B. Buller, Julia Berteletti, and Irene Adjei are with Klein Buendel Inc, Golden, CO. Carolyn Heckman and Anna Mitarotondo are with the Rutgers Cancer Institute, Rutgers University, New Brunswick, NJ. Kevin R. J. Schroth is with the School of Public Health, Rutgers University, New Brunswick. Alan C. Geller is with the T. H. Chan School of Public Health, Harvard University, Cambridge, MA. Jerod L. Stapleton is with the College of Public Health, University of Kentucky, Lexington. Samantha R. Guild is with the AIM at Melanoma Foundation, Frisco, TX. Jeffrey E. Gershenwald is with the M D Andersen Cancer Center, University of Texas, Houston. Robert Dellavalle is with the Medical School, University of Minnesota, Minneapolis. Sherry Pagoto is with the Department of Allied Health Sciences, University of Connecticut, Storrs., Geller AC; David B. Buller, Julia Berteletti, and Irene Adjei are with Klein Buendel Inc, Golden, CO. Carolyn Heckman and Anna Mitarotondo are with the Rutgers Cancer Institute, Rutgers University, New Brunswick, NJ. Kevin R. J. Schroth is with the School of Public Health, Rutgers University, New Brunswick. Alan C. Geller is with the T. H. Chan School of Public Health, Harvard University, Cambridge, MA. Jerod L. Stapleton is with the College of Public Health, University of Kentucky, Lexington. Samantha R. Guild is with the AIM at Melanoma Foundation, Frisco, TX. Jeffrey E. Gershenwald is with the M D Andersen Cancer Center, University of Texas, Houston. Robert Dellavalle is with the Medical School, University of Minnesota, Minneapolis. Sherry Pagoto is with the Department of Allied Health Sciences, University of Connecticut, Storrs., Stapleton JL; David B. Buller, Julia Berteletti, and Irene Adjei are with Klein Buendel Inc, Golden, CO. Carolyn Heckman and Anna Mitarotondo are with the Rutgers Cancer Institute, Rutgers University, New Brunswick, NJ. Kevin R. J. Schroth is with the School of Public Health, Rutgers University, New Brunswick. Alan C. Geller is with the T. H. Chan School of Public Health, Harvard University, Cambridge, MA. Jerod L. Stapleton is with the College of Public Health, University of Kentucky, Lexington. Samantha R. Guild is with the AIM at Melanoma Foundation, Frisco, TX. Jeffrey E. Gershenwald is with the M D Andersen Cancer Center, University of Texas, Houston. Robert Dellavalle is with the Medical School, University of Minnesota, Minneapolis. Sherry Pagoto is with the Department of Allied Health Sciences, University of Connecticut, Storrs., Adjei I; David B. Buller, Julia Berteletti, and Irene Adjei are with Klein Buendel Inc, Golden, CO. Carolyn Heckman and Anna Mitarotondo are with the Rutgers Cancer Institute, Rutgers University, New Brunswick, NJ. Kevin R. J. Schroth is with the School of Public Health, Rutgers University, New Brunswick. Alan C. Geller is with the T. H. Chan School of Public Health, Harvard University, Cambridge, MA. Jerod L. Stapleton is with the College of Public Health, University of Kentucky, Lexington. Samantha R. Guild is with the AIM at Melanoma Foundation, Frisco, TX. Jeffrey E. Gershenwald is with the M D Andersen Cancer Center, University of Texas, Houston. Robert Dellavalle is with the Medical School, University of Minnesota, Minneapolis. Sherry Pagoto is with the Department of Allied Health Sciences, University of Connecticut, Storrs., Mitarotondo A; David B. Buller, Julia Berteletti, and Irene Adjei are with Klein Buendel Inc, Golden, CO. Carolyn Heckman and Anna Mitarotondo are with the Rutgers Cancer Institute, Rutgers University, New Brunswick, NJ. Kevin R. J. Schroth is with the School of Public Health, Rutgers University, New Brunswick. Alan C. Geller is with the T. H. Chan School of Public Health, Harvard University, Cambridge, MA. Jerod L. Stapleton is with the College of Public Health, University of Kentucky, Lexington. Samantha R. Guild is with the AIM at Melanoma Foundation, Frisco, TX. Jeffrey E. Gershenwald is with the M D Andersen Cancer Center, University of Texas, Houston. Robert Dellavalle is with the Medical School, University of Minnesota, Minneapolis. Sherry Pagoto is with the Department of Allied Health Sciences, University of Connecticut, Storrs., Guild SR; David B. Buller, Julia Berteletti, and Irene Adjei are with Klein Buendel Inc, Golden, CO. Carolyn Heckman and Anna Mitarotondo are with the Rutgers Cancer Institute, Rutgers University, New Brunswick, NJ. Kevin R. J. Schroth is with the School of Public Health, Rutgers University, New Brunswick. Alan C. Geller is with the T. H. Chan School of Public Health, Harvard University, Cambridge, MA. Jerod L. Stapleton is with the College of Public Health, University of Kentucky, Lexington. Samantha R. Guild is with the AIM at Melanoma Foundation, Frisco, TX. Jeffrey E. Gershenwald is with the M D Andersen Cancer Center, University of Texas, Houston. Robert Dellavalle is with the Medical School, University of Minnesota, Minneapolis. Sherry Pagoto is with the Department of Allied Health Sciences, University of Connecticut, Storrs., Gershenwald JE; David B. Buller, Julia Berteletti, and Irene Adjei are with Klein Buendel Inc, Golden, CO. Carolyn Heckman and Anna Mitarotondo are with the Rutgers Cancer Institute, Rutgers University, New Brunswick, NJ. Kevin R. J. Schroth is with the School of Public Health, Rutgers University, New Brunswick. Alan C. Geller is with the T. H. Chan School of Public Health, Harvard University, Cambridge, MA. Jerod L. Stapleton is with the College of Public Health, University of Kentucky, Lexington. Samantha R. Guild is with the AIM at Melanoma Foundation, Frisco, TX. Jeffrey E. Gershenwald is with the M D Andersen Cancer Center, University of Texas, Houston. Robert Dellavalle is with the Medical School, University of Minnesota, Minneapolis. Sherry Pagoto is with the Department of Allied Health Sciences, University of Connecticut, Storrs., Dellavalle R; David B. Buller, Julia Berteletti, and Irene Adjei are with Klein Buendel Inc, Golden, CO. Carolyn Heckman and Anna Mitarotondo are with the Rutgers Cancer Institute, Rutgers University, New Brunswick, NJ. Kevin R. J. Schroth is with the School of Public Health, Rutgers University, New Brunswick. Alan C. Geller is with the T. H. Chan School of Public Health, Harvard University, Cambridge, MA. Jerod L. Stapleton is with the College of Public Health, University of Kentucky, Lexington. Samantha R. Guild is with the AIM at Melanoma Foundation, Frisco, TX. Jeffrey E. Gershenwald is with the M D Andersen Cancer Center, University of Texas, Houston. Robert Dellavalle is with the Medical School, University of Minnesota, Minneapolis. Sherry Pagoto is with the Department of Allied Health Sciences, University of Connecticut, Storrs., Pagoto S; David B. Buller, Julia Berteletti, and Irene Adjei are with Klein Buendel Inc, Golden, CO. Carolyn Heckman and Anna Mitarotondo are with the Rutgers Cancer Institute, Rutgers University, New Brunswick, NJ. Kevin R. J. Schroth is with the School of Public Health, Rutgers University, New Brunswick. Alan C. Geller is with the T. H. Chan School of Public Health, Harvard University, Cambridge, MA. Jerod L. Stapleton is with the College of Public Health, University of Kentucky, Lexington. Samantha R. Guild is with the AIM at Melanoma Foundation, Frisco, TX. Jeffrey E. Gershenwald is with the M D Andersen Cancer Center, University of Texas, Houston. Robert Dellavalle is with the Medical School, University of Minnesota, Minneapolis. Sherry Pagoto is with the Department of Allied Health Sciences, University of Connecticut, Storrs.
Publikováno v:
American journal of public health [Am J Public Health] 2024 Nov 21, pp. e1-e10. Date of Electronic Publication: 2024 Nov 21.
Autor:
Amaral T; Skin Cancer Clinical Trials Center-University of Tuebingen, Tuebingen, Germany., Ottaviano M; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Napoli, Italy., Arance A; Department of Medical Oncology and IDIBAPS, Hospital Clinic y Provincial de Barcelona, Barcelona, Spain., Blank C; Department of Medical Oncology and Division of Immunology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Ziekenhuis (NKI), Amsterdam; Leiden University Medical Center (LUMC), Leiden, The Netherlands; University Clinic Regensburg, Regensburg, Germany., Chiarion-Sileni V; Department of Oncology, Melanoma Unit, Istituto Oncologico Veneto, IOV-IRCCS, Padova, Italy., Donia M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital Herlev and Gentofte, Herlev, Denmark., Dummer R; Department of Dermatology, Skin Cancer Center, USZ-University Hospital Zürich, University of Zürich, Zürich, Switzerland., Garbe C; Department of Dermatology, Center for DermatoOncology, University Hospital Tuebingen, Tuebingen, Germany., Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center and The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, USA., Gogas H; First Department of Medicine, School of Medicine, National and Kapodistrian University of Athens-School of Medicine, Athens, Greece., Guckenberger M; Department of Radiation Oncology, University Hospital Zürich, University of Zürich, Zürich, Switzerland., Haanen J; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Medical Oncology, Leiden University Medical Center (LUMC), Leiden, The Netherlands; Oncology Service, Melanoma Clinic, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland., Hamid O; Medical Oncology, Cutaneous Malignancies, The Angeles Clinic and Research Institute, A Cedars Sinai Affiliate, Los Angeles, USA., Hauschild A; Department of Dermatology, UKSH-Universitätsklinikum Schleswig-Holstein-Campus Kiel, Kiel, Germany., Höller C; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Lebbé C; Université Paris Cite, AP-HP Dermato-oncology and CIC, Cancer Institute APHP, Nord Paris Cité, INSERM U976, Saint Louis Hospital, Paris, France., Lee RJ; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Department Medical Oncology, Royal North Shore Hospital, Sydney, Australia; Mater Hospital, Sydney, Australia., Lorigan P; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK., Muñoz Couselo E; Department of Medical Oncology, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Nathan P; Mount Vernon Cancer Centre, Northwood, UK., Robert C; Department of Oncology, Institut Gustave Roussy and Paris-Saclay University, Villejuif, France., Romano E; Department of Oncology, Center for Cancer Immunotherapy, Institut Curie, Paris, France., Schadendorf D; Department of Dermatology, WTZ-Westdeutsches Tumorzentrum Essen, National Center for Tumor Diseases (NCT-West), Campus Essen, Essen, Germany; University Alliance Ruhr, Research Center One Health, University Duisburg-Essen, Essen, Germany., Sondak V; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, USA., Suijkerbuijk KPM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., van Akkooi ACJ; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia., Michelin O; Department of Oncology, Geneva University Hospital, Geneva, Switzerland., Ascierto PA; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Instituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Nov 14. Date of Electronic Publication: 2024 Nov 14.
Autor:
Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Unit 1484, P.O. Box 301402, Houston, TX, 77230-1402, USA. jgershen@mdanderson.org.
Publikováno v:
Annals of surgical oncology [Ann Surg Oncol] 2023 Oct; Vol. 30 (11), pp. 6325-6331. Date of Electronic Publication: 2023 Jul 26.
Autor:
Turcios Escobar S; Department of Pathology, University of Illinois Hospital & Health Sciences System, Chicago, Illinois, USA., Yang R; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Nelson KC; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Tawbi H; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Aung PP; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Patel SP; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Torres-Cabala CA; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
Journal of cutaneous pathology [J Cutan Pathol] 2024 Sep; Vol. 51 (9), pp. 644-648. Date of Electronic Publication: 2024 May 16.
Autor:
Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
Cancer [Cancer] 2023 Aug 01; Vol. 129 (15), pp. 2290-2293. Date of Electronic Publication: 2023 May 10.
Autor:
Varey AHR; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Department of Plastic & Reconstructive Surgery, Westmead Hospital, Sydney, NSW, Australia., Li I; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., El Sharouni MA; Departments of Dermatology and Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Simon J; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Dedeilia A; Massachusetts General Hospital, Boston, MA., Ch'ng S; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia.; Institute of Academic Surgery at RPA, Sydney Local Health District, Sydney, NSW, Australia., Saw RPM; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia., Spillane AJ; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Shannon KF; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia., Pennington TE; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia., Rtshiladze M; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia., Stretch JR; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia., Nieweg OE; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia., van Akkooi A; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia., Sullivan RJ; Massachusetts General Hospital, Boston, MA., Boland GM; Massachusetts General Hospital, Boston, MA., Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., van Diest PJ; Departments of Dermatology and Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW, Australia., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia., Thompson JF; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia., Lo SN; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Apr 01; Vol. 42 (10), pp. 1169-1180. Date of Electronic Publication: 2024 Feb 05.
Autor:
Asare EA; Department of Surgery, University of Utah Huntsman Cancer Institute, Salt Lake City, Utah, USA., Fisher SB; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Chiang YJ; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Haydu LE; Department of Biostatistics, United States Air Force Special Warfare Training Wing, Joint Base San Antonio, Lackland, Bexar County, Texas, USA., Patel SH; Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA., Keung EZ; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lucci A; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Wargo J; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ross MI; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lee JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
Journal of surgical oncology [J Surg Oncol] 2023 Aug; Vol. 128 (2), pp. 313-321. Date of Electronic Publication: 2023 Apr 03.
Health Economic Consequences Associated With COVID-19-Related Delay in Melanoma Diagnosis in Europe.
Autor:
Maul LV; Department of Dermatology, University Hospital of Basel, Basel, Switzerland.; Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland.; Faculty of Medicine, University of Zurich, Zurich, Switzerland., Jamiolkowski D; Department of Dermatology, University Hospital of Basel, Basel, Switzerland.; Division of Pediatric Dermatology, Children's Hospital Auf der Bult, Hannover, Germany., Lapides RA; Robert Larner, MD, College of Medicine at the University of Vermont, Burlington, Vermont.; Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Charlestown., Mueller AM; Department of Dermatology, University Hospital of Basel, Basel, Switzerland., Hauschild A; Department of Dermatology, University Hospital of Schleswig-Holstein, Campus Kiel, Kiel, Germany., Garbe C; Center for Dermatooncology, Department of Dermatology, Eberhard Karls University of Tuebingen, Tuebingen, Germany., Lorigan P; Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom.; The Christie NHS Foundation Trust, Manchester, United Kingdom., Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston., Ascierto PA; Istituto Nazionale Tumori, IRCCS, Fondazione G Pascale, Naples, Italy., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; Royal North Shore Hospital, Sydney, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, Australia., Wang-Evers M; Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Charlestown., Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, Australia., Saravi B; Department of Orthopedics and Trauma Surgery, Medical Center-University of Freiburg, Germany.; Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Augustin M; University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Navarini AA; Department of Dermatology, University Hospital of Basel, Basel, Switzerland., Legge S; Institute of Law and Economics, University of St Gallen, St Gallen, Switzerland., Németh IB; Department of Dermatology and Allergology, University of Szeged, Szent-Györgyi Albert Medical School, Szeged, Hungary., Jánosi ÁJ; Department of Dermatology and Allergology, University of Szeged, Szent-Györgyi Albert Medical School, Szeged, Hungary., Mocellin S; Soft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, Istituto Oncologico Veneto - IRCCS, Padua, Italy.; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy., Feller A; National Agency for Cancer Registration, University of Zurich, Zurich, Switzerland.; Foundation National Institute for Cancer Epidemiology and Registration, University of Zurich, Zurich, Switzerland., Manstein D; Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Charlestown., Zink A; Department of Dermatology and Allergy, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany., Maul JT; Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland.; Faculty of Medicine, University of Zurich, Zurich, Switzerland., Buja A; Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Via Loredan, Padova, Italy., Adhikari K; School of Mathematics and Statistics, Faculty of Science, Technology, Engineering and Mathematics, The Open University, Milton Keynes, United Kingdom.; Department of Genetics, Evolution and Environment, and UCL Genetics Institute, University College London, London, United Kingdom., Roider E; Department of Dermatology, University Hospital of Basel, Basel, Switzerland.; Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Charlestown.
Publikováno v:
JAMA network open [JAMA Netw Open] 2024 Feb 05; Vol. 7 (2), pp. e2356479. Date of Electronic Publication: 2024 Feb 05.
Autor:
Cui C; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, Beijing, 100142, China., Lian B; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, Beijing, 100142, China., Zhang X; Melanoma and Sarcoma Medical Oncology Unit, Biotherapy Center, SUN YAT-SEN University Cancer Center, Guangzhou, China., Wu D; Cancer center, The First Hospital of Jilin University, Changchun, China., Li K; Department of Cancer Biotherapy Center, Yunnan Cancer Hospital, Kunming, China., Si L; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, Beijing, 100142, China., Yang Y; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, Beijing, 100142, China., Tian H; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, Beijing, 100142, China., Zhou L; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, Beijing, 100142, China., Chi Z; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, Beijing, 100142, China., Sheng X; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, Beijing, 100142, China., Kong Y; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, Beijing, 100142, China., Mao L; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, Beijing, 100142, China., Wang X; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, Beijing, 100142, China., Bai X; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, Beijing, 100142, China., Yan X; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, Beijing, 100142, China., Li S; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, Beijing, 100142, China., Dai J; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, Beijing, 100142, China., Tang B; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, Beijing, 100142, China., Wei X; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, Beijing, 100142, China., Gershenwald JE; Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA., Balch CM; Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA., Guo J; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital and Institute, Beijing, 100142, China. guoj307@126.com.
Publikováno v:
Annals of surgical oncology [Ann Surg Oncol] 2022 Aug; Vol. 29 (8), pp. 5221-5234. Date of Electronic Publication: 2022 Apr 09.
Autor:
Wei AZ; Columbia University Irving Medical Center, New York, New York, USA., Chen LN; Columbia University Irving Medical Center, New York, New York, USA., Orloff M; Thomas Jefferson University Sidney Kimmel Cancer Center, Philadelphia, Pennsylvania, USA., Ariyan CE; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Asgari M; Harvard Medical School, Boston, Massachusetts, USA., Barker CA; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Buchbinder E; Dana-Farber Cancer Institute/Harvard Cancer Center, Boston, Massachusetts, USA., Chandra S; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Couts K; University of Colorado School of Medicine, Aurora, Colorado, USA., Frumovitz MM; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Futreal A; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Gershenwald JE; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hanna EY; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Izar B; Columbia University Irving Medical Center, New York, New York, USA., LeBlanc AK; National Institute of Health, Bethesda, Maryland, USA., Leitao MM Jr; Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of Obstetrics and Gynecology, Weill Cornell Medical College, New York, New York, USA., Lipson EJ; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Liu D; Dana-Farber Cancer Institute/Harvard Cancer Center, Boston, Massachusetts, USA., McCarter M; University of Colorado School of Medicine, Aurora, Colorado, USA., McQuade JL; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Najjar Y; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania, USA., Rapisuwon S; Georgetown University/MedStar Health, Washington, DC, USA., Selig S; Melanoma Research Foundation, CURE OM, Washington, DC, USA., Shoushtari AN; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Yeh I; University of California, San Francisco, San Francisco, California, USA., Schwartz GK; Case Comprehensive Cancer Center, Cleveland, Ohio, USA., Guo J; Peking University Cancer Hospital & Institute, Beijing, China., Patel SP; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Carvajal RD; Northwell Health Cancer Institute, New Hyde Park, New York, USA.
Publikováno v:
Pigment cell & melanoma research [Pigment Cell Melanoma Res] 2023 Nov; Vol. 36 (6), pp. 542-556. Date of Electronic Publication: 2023 Oct 07.